-
Mashup Score: 1Decoding Recurrent Brain Metastases: The Power of 18F-Fluciclovine PET - 10 month(s) ago
Decoding Recurrent Brain Metastases: The Power of 18F-Fluciclovine PET This discusses the challenges in detecting recurrent brain metastases and the potential of 18F-Fluciclovine PET as a diagnostic tool. Brain metastases occur when cancer cells spread from their original site to the brain and effect around 10-30% o…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The combination of paxalisib and radiotherapy exhibited complete or partial responses in all patients with brain metastases, according to interim data from an ongoing phase I clinical trial.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2How I treat brain metastases of melanoma - 1 year(s) ago
Brain metastases are common in advanced melanoma and cause death in >50% of patients. Until recently, median survival was only ā¼4 months. Improved systemic treatment including immune checkpoint inhibitors and combinations of BRAF/MEK inhibitors, however, has significantly improved intracranial tumor response and survival. In addition, advances in radiation therapy have also improved the…
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0The Cancer News Daily - 1 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2PD-L1 Expression in Breast Cancer Brain Metastases - 2 year(s) ago
AbstractBackground. To evaluate potential intracranial efficacy of immunotherapy among patients with breast cancer brain metastases (BrM), we analyzed the immun
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Abstract. Brain metastases (BM) are associated with significant morbidity and mortality in patients with advanced cancer. Despite significant advances in surgic
Source: OUP AcademicCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Management of Advanced Human Epidermal Growth Factor Receptor 2āPositive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A - 2 year(s) ago
ASCO recently published an updated guideline for the management of advanced human epidermal growth factor receptor 2 (HER2)āpositive breast cancer and brain metastases,1 along with a companion guideline on systemic therapy for patients with HER2-positive advanced breast cancer.2 Recent data on local therapy and systemic therapy advances for patients with HER2-positive advanced breast cancer and…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#JCOOP @ASCO Guideline Update #QandA: Management of Advanced #HER2āPositive #BreastCancer and #BrainMetastases. Given local tx and systemic tx advances, authors address selecting the appropriate treatment and surveillance regimens. ā”ļø https://t.co/bepG4fFX4P #bcsm #brainmets https://t.co/c4xTGFprtx
-
-
Mashup Score: 2Management of Advanced Human Epidermal Growth Factor Receptor 2āPositive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A - 2 year(s) ago
ASCO recently published an updated guideline for the management of advanced human epidermal growth factor receptor 2 (HER2)āpositive breast cancer and brain metastases,1 along with a companion guideline on systemic therapy for patients with HER2-positive advanced breast cancer.2 Recent data on local therapy and systemic therapy advances for patients with HER2-positive advanced breast cancer and…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Background Brain metastases (BMs) are the most serious complication of lung cancer, affecting the prognosis of lung cancer patients, and pose distinct clinical challenges. This study was designed to explore the prognostic factors related to lung cancer BM and the value of surgical resection in BMs from lung cancer. Methods A retrospective analysis was performed on 714 patients with lung cancer…
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
š¬ Today at the ASCO Annual Meeting 2023, where groundbreaking advancements in cancer research and treatment are taking center stage! š New on OncologyTube! š„ https://t.co/FMSZbAdLuE The Power of 18F-Fluciclovine PET Dr. @Rrkotecha @MiamiCancerInst #BrainMetastases #ASCO23 https://t.co/Od9RjrpolB